Genelux
NASDAQ: GNLXWestlake Village, US · Delaware corporation
Biotech
Founders & leadership
PS
Paul ScigallaExecutive Officer
GW
Gabe WoodwardDirector
TZ
Thomas ZindrickExecutive Officer, Director
MM
Mary MirabelliDirector
JT
John ThomasDirector
DS
Doug SamuelsonExecutive Officer
JT
James TyreeDirector
Reported raises · per SEC filings
Form D private placements▶$5.5MraisedJun 2023 · 19 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Mary MirabelliDirector
- Thomas ZindrickExecutive Officer, Director
- Doug SamuelsonExecutive Officer
- Gabe WoodwardDirector
- Paul ScigallaExecutive Officer
- James TyreeDirector
- John ThomasDirector
- Offering amount
- $18M
- Amount sold
- $5.5M
- Finders' fees
- $200K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.3MraisedJun 2023 · 69 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Paul ScigallaExecutive Officer
- Gabe WoodwardDirector
- Thomas ZindrickExecutive Officer, Director
- Mary MirabelliDirector
- John ThomasDirector
- Doug SamuelsonExecutive Officer
- James TyreeDirector
- Offering amount
- $33.3M
- Amount sold
- $18.3M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.